‘Vast Amount Of Valuable Input’ Leads Australia To Extend HTA Review
A second public consultation on the review of the HTA system will be held in January to February 2024 after more than 100 stakeholder responses were received during the first consultation earlier this year.
You may also be interested in...
Shortcomings in the health technology assessment system are discouraging some companies from investing in Australia, according to responses to a recent consultation on the ongoing HTA review.
Stakeholders wishing to contribute to the review of health technology assessment policies and methods will be able to do so by making online submissions or taking part in virtual forums, and should be prepared to offer experiences and examples to help pinpoint the key options for reform.
New EU guidance will cover non-clinical and clinical development, trial design, endpoints, safety issues and comparators, as well as the use of immunobridging studies.